140410 — Mezzion Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Mezzion Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	49,104	47,210	32,399	58,246	28,617
Net Total Accounts Receivable
Net Total Receivables	4,248	4,591	4,363	6,031	1,757
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	60,669	64,174	45,897	74,244	41,926
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,899	4,879	4,245	2,854	2,529
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	75,625	83,935	54,022	92,149	73,998
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15,514	18,497	26,080	29,615	26,670
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	18,816	21,141	27,782	30,705	27,935
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	56,810	62,793	26,240	61,444	46,063
Total Liabilities & Shareholders' Equity	75,625	83,935	54,022	92,149	73,998
Total Common Shares Outstanding